Evolution of antibody response and fungal antigens in the serum of a patient infected with Candida famata

Journal of Medical Microbiology

Volumn 56, Issue 5, 2007, Pages 571-578

  Pisa, Diana ^a   Ramos, Marta ^a   Molina, Susana ^a   García, Patricia ^a   Carrasco, Luis ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGUS ANTIBODY; FUNGUS ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN M; PYROXYLIN;

ADULT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BLOOD ANALYSIS; CANDIDIASIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNODETECTION; IMMUNOFLUORESCENCE TEST; IMMUNOREACTIVITY; INCUBATION TIME; PRIORITY JOURNAL; RETINOPATHY; SENSITIVITY ANALYSIS;

ANTIBODIES, FUNGAL; ANTIFUNGAL AGENTS; ANTIGENS, FUNGAL; CANDIDA; CANDIDIASIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN M; MICROSCOPY, IMMUNOELECTRON; MIDDLE AGED; RETINAL DISEASES; SERUM;

EID: 34248209633     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.47042-0     Document Type: Article

References (55)

1. Al-Hedaithy, S. S. (2003). The yeast species causing fungemia at a university hospital in Riyadh, Saudi Arabia, during a 10-year period. Mycoses 46, 293-298.
2. Almirante, B., Rodriguez, D., Cuenca-Estrella, M., Almela, M., Sanchez, F., Ayats, J., Alonso-Tarres, C., Rodriguez-Tudela, J. L. & Pahissa, A. (2006). Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 44, 1681-1685.
3. Altamura, M., Casale, D., Pepe, M. & Tafaro, A. (2001). Immune responses to fungal infections and therapeutic implications. Curr Drug Targets Immune Endocr Metabol Disord 1, 189-197.
4. Andrighetto, C., Psomas, E., Tzanetakis, N., Suzzi, G. & Lombardi, A. (2000). Randomly amplified polymorphic DNA (RAPD) PCR for the identification of yeasts isolated from dairy products. Lett Appl Microbiol 30, 5-9.
5. Badauy, C. M., Barbachan, J. J., Rados, P. V., Sant'ana Filho, M. & Chies, J. A. (2005). Relationship between Candida infection and immune cellular response in inflammatory hyperplasia. Oral Microbiol Immunol 20, 89-92.
6. Brandt, M. E., Harrison, L. H., Pass, M., Sofair, A. N., Huie, S., Li, R. K., Morrison, C. J., Warnock, D. W. & Hajjeh, R. A. (2000). Candida dubliniensis fungemia: the first four cases in North America. Emerg Infect Dis 6, 46-49.
7. Bretagne, S. & Costa, J. M. (2005). Towards a molecular diagnosis of invasive aspergillosis and disseminated candidosis. FEMS Immunol Med Microbiol 45, 361-368.
8. Canteros, G. E., Davel, G. O. & Vivot, W. (1994). Causal agents of onychomycosis. Rev Argent Microbiol 26, 65-71 (in Spanish)
9. Carrasco, L., Ramos, M., Galisteo, R., Pisa, D., Fresno, M. & Gonzalez, M. E. (2005). Isolation of Candida famata from a patient with acute zonal occult outer retinopathy. J Clin Microbiol 43, 635-640.
10. Clemons, K. V., Calich, V. L., Burger, E., Filler, S. G., Grazziutti, M., Murphy, J., Roilides, E., Campa, A., Dias, M. R. & other authors (2000). Pathogenesis I: interactions of host cells and fungi. Med Mycol 38 (Suppl. 1), 99-111.
11. Coleman, D. C., Rinaldi, M. G., Haynes, K. A., Rex, J. H., Summerbell, R. C., Anaissie, E. J., Li, A. & Sullivan, D. J. (1998). Importance of Candida species other than Candida albicans as opportunistic pathogens. Med Mycol 36 (Suppl. 1), 156-165.
12. d'Ostiani, C. F., Del Sero, G., Bacci, A., Montagnoli, C., Spreca, A., Mencacci, A., Ricciardi-Castagnoli, P. & Romani, L. (2000). Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J Exp Med 191, 1661-1674.
13. Einsele, H., Hebart, H., Roller, G., Loffler, J., Rothenhofer, I., Muller, C. A., Bowden, R. A., van Burik, J., Engelhard, D. & other authors (1997). Detection and identification of fungal pathogens in blood by using molecular probes. J Clin Microbiol 35, 1353-1360.
14. Ellepola, A. N. & Morrison, C. J. (2005). Laboratory diagnosis of invasive candidiasis. J Microbiol 43, 65-84.
15. Fanci, R., Guidi, S., Bonolis, M. & Bosi, A. (2005). Candida krusei fungemia in an unrelated allogeneic hematopoietic stem cell transplant patient successfully treated with caspofungin. Bone Marrow Transplant 35, 1215-1216.
16. Fernandez-Arenas, E., Molero, G., Nombela, C., Diez-Orejas, R. & Gil, C. (2004). Contribution of the antibodies response induced by a low virulent Candida albicans strain in protection against systemic candidiasis. Proteomics 4, 1204-1215.
17. Garcia-Gonzalez, A. & Ochoa, J. L. (1999). Anti-inflammatory activity of Debaryomyces hansenii Cu,Zn-SOD. Arch Med Res 30, 69-73.
18. Gardini, F., Suzzi, G., Lombardi, A., Galgano, F., Crudele, M. A., Andrighetto, C., Schirone, M. & Tofalo, R. (2001). A survey of yeasts in traditional sausages of southern Italy. FEMS Yeast Res 1, 161-167.
19. Gil, M. (1997). Conceptos básicos sobre la interacción del sistema inmune y los hongos causales de micosis sistémicas. IATREIA 10, 171-176.
20. Ishibashi, K., Yoshida, M., Nakabayashi, I., Shinohara, H., Miura, N. N., Adachi, Y. & Ohno, N. (2005). Role of anti-β-glucan antibody in host defense against fungi. FEMS Immunol Med Microbiol 44, 99-109.
21. Khan, Z. U. & Mustafa, A. S. (2001). Detection of Candida species by polymerase chain reaction (PCR) in blood samples of experimentally infected mice and patients with suspected candidemia. Microbiol Res 156, 95-102.
22. Krcmery, V. & Barnes, A. J. (2002). Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 50, 243-260.
23. Krcmery, V. & Kunova, A. (2000). Candida famata fungemia in a cancer patient: case report. J Chemother 12, 189-190.
24. Li, Y. L., Leaw, S. N., Chen, J. H., Chang, H. C. & Chang, T. C. (2003). Rapid identification of yeasts commonly found in positive blood cultures by amplification of the internal transcribed spacer regions 1 and 2. Eur J Clin Microbiol Infect Dis 22, 693-696.
25. Lopez-Ribot, J. L., Casanova, M., Murgui, A. & Martinez, J. P. (2004). Antibody response to Candida albicans cell wall antigens. FEMS Immunol Med Microbiol 41, 187-196.
26. Matthews, R. & Burnie, J. (1998). The epidemiology and pathogenesis of candidiasis: application in prevention and treatment. Bull Inst Pasteur 96, 249-256.
27. Mencacci, A., Cenci, E., Del Sero, G., d'Ostiani, C. F., Montagnoli, C., Bacci, A., Bistoni, F. & Romani, L. (1999). Innate and adaptive immunity to Candida albicans: a new view of an old paradigm. Rev Iberoam Micol 16, 4-7.
28. Mitsutake, K., Miyazaki, T., Tashiro, T., Yamamoto, Y., Kakeya, H., Otsubo, T., Kawamura, S., Hossain, M. A., Noda, T. & other authors (1996). Enolase antigen, mannan antigen, Cand-Tec antigen, and β-glucan in patients with candidemia. J Clin Microbiol 34, 1918-1921.
29. Nishikawa, A., Sugita, T. & Shinoda, T. (1999). Rapid identification of Debaryomyces hansenii/ Candida famata by polymerase chain reaction. Med Mycol 37, 101-104.
30. Pazos, C., Ponton, J. & Del Palacio, A. (2005). Contribution of (1→3)-β-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 43, 299-305.
31. Peres-Bota, D., Rodriguez-Villalobos, H., Dimopoulos, G., Melot, C. & Vincent, J. L. (2004). Potential risk factors for infection with Candida spp. in critically ill patients. Clin Microbiol Infect 10, 550-555.
32. Pfaller, M. A. (1996). Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin Infect Dis 22 (Suppl. 2), S89-S94.
33. Pfaller, M. A., Diekema, D. J., Messer, S. A., Boyken, L., Hollis, R. J. & Jones, R. N. (2003). In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood. J Clin Microbiol 41, 78-83.
34. Pontȯn, J. (2006). El diagnóstico microbioló gico independiente de cultivo en la candidiasis invasora. Importanciae los marcadores fúngicos. Rev Iberoam Micol 23, 20-25.
35. Prinsloo, B., Weldhagen, G. F. & Blaine, R. W. (2003). Candida famata central nervous system infection. S Afr Med J 93, 601-602.
36. Pryce, T. M., Kay, I. D., Palladino, S. & Heath, C. H. (2003). Real-time automated polymerase chain reaction (PCR) to detect Candida albicans and Aspergillus fumigatus DNA in whole blood from high-risk patients. Diagn Microbiol Infect Dis 47, 487-496.
37. Quindos, G., Moragues, M. D. & Ponton, J. (2004). Is there a role for antibody testing in the diagnosis of invasive candidiasis? Rev Iberoam Micol 21, 10-14.
38. Rao, N. A., Nerenberg, A. V. & Forster, D. J. (1991). Torulopsis candida (Candida famata) endophthalmitis simulating Propionibacterium acnes syndrome. Arch Ophthalmol 109, 1718-1721.
39. Reboli, A. C. (1993). Diagnosis of invasive candidiasis by a dot immunobinding assay for Candida antigen detection. J Clin Microbiol 31, 518-523.
40. Rozell, B., Ljungdahl, P. O. & Martinez, P. (2006). Host-pathogen interactions and the pathological consequences of acute systemic Candida albicans infections in mice. Curr Drug Targets 7, 483-494.
41. Ruhnke, M. (2006). Epidemiology of Candida albicans infections and role of non-Candida albicans yeasts. Curr Drug Targets 7, 495-504.
42. Shoham, S. & Levitz, S. M. (2005). The immune response to fungal infections. Br J Haematol 129, 569-582.
43. Simitsopoulou, M. & Roilides, E. (2005). Evaluation of immunotherapy in invasive candidiasis: antifungal activity and cytokine expression assays. Methods Mol Med 118, 161-179.
44. Sims, C. R., Ostrosky-Zeichner, L. & Rex, J. H. (2005). Invasive candidiasis in immunocompromised hospitalized patients. Arch Med Res 36, 660-671.
45. St-Germain, G. & Laverdiere, M. (1986). Torulopsis candida, a new opportunistic pathogen. J Clin Microbiol 24, 884-885.
46. Tortorano, A. M., Kibbler, C., Peman, J., Bernhardt, H., Klingspor, L. & Grillot, R. (2006). Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents 27, 359-366.
47. van Deventer, A. J. M., Goessens, W. H. F., van Belkum, H. J. A., van Vliet, H. J. A., van Etten, E. W. M. & Verbrugh, H. A. (1995). Improved detection of Candida albicans by PCR in blood of neutropenic mice with systemic candidiasis. J Clin Microbiol 33, 625-628.
48. Veldman, B. A., Verweij, P. E. & Blijlevens, N. M. (2006). Successful treatment of liposomal amphotericin B refractory Candida glabrata fungaemia in a patient undergoing a stem cell transplantation. Neth J Med 64, 127-129.
49. Villar, C. C., Kashleva, H., Mitchell, A. P. & Dongari-Bagtzoglou, A. (2005). Invasive phenotype of Candida albicans affects the host proinflammatory response to infection. Infect Immun 73, 4588-4595.
50. Wagner, D., Sander, A., Bertz, H., Finke, J. & Kern, W. V. (2005). Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis. Infection 33, 397-400.
51. Witkin, S. S., Yu, I. R. & Ledger, W. J. (1983). Inhibition of Candida albicans-induced lymphocyte proliferation by lymphocytes and sera from women with recurrent vaginitis. Am J Obstet Gynecol 147, 809-811.
52. Wright, R., Basson, M., D'Ari, L. & Rine, J. (1988). Increased amounts of HMG-CoA reductase induce "Karmellae": a proliferation of stacked membrane pairs surrounding the yeast nucleus. J Cell Biol 107, 101-114.
53. Yamamoto, Y., Osanai, S., Fujiuchi, S., Yamazaki, K., Nakano, H., Ohsaki, Y. & Kikuchi, K. (2002). Extrinsic allergic alveolitis induced by the yeast Debaryomyces hansenii. Eur Respir J 20, 1351-1353.
54. Yang, C. W., Barkham, T. M., Chan, F. Y. & Wang, Y. (2003). Prevalence of Candida species, including Candida dubliniensis, in Singapore. J Clin Microbiol 41, 472-474.
55. Yeo, S. F. & Wong, B. (2002). Current status of nonculture methods for diagnosis of invasive fungal infections. Clin Microbiol Rev 15, 465-484.